GENOMIC SEQUENCING CENTER FOR INFECTIOUS DISEASES
The JCVI Genomic Sequencing Center for Infectious Diseases (GSCID), sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), addresses the scientific community's need for sequencing and genotyping of organisms considered agents of bioterrorism and/or responsible for emerging and re-emerging diseases. The program overview can be downloaded here.
The NIAID/GSCID is accepting white papers for the study of organisms that are considered agents of bioterrorism or cause emerging or re-emerging infectious diseases and their related strains or species. [Read more]
26-Jul-2010 — ASTMH
Tropical Medicine and Hygiene News: GSCID accepting applications
29-Apr-2010 — IDSA
IDSA works with Federal Partners to Address Antibiotic Resistance
22-Apr-2010 — Microbe World
Microbe World: GSCID funded by NIAID are accepting applications for sequencing projects
9-Jun-2010 — GenomeWeb
New Sequencing Technologies Reshape NIAID's Sequencing Centers; Contracts Total $106M